GIP and obesity disorder: Peptide analogues based on a naturally occurring C‐ and N‐terminally truncated GIP variant, GIP(3‐30)NH2, were found to antagonize the GIP receptor and reduced obesity and improved metabolic control in mice (Hansen et al., 2016; Pathak et al., 2015).